Benjamin Edwards Inc’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,491
| Closed | -$224K | – | 1155 |
|
2025
Q1 | $224K | Buy |
1,491
+6
| +0.4% | +$903 | ﹤0.01% | 1012 |
|
2024
Q4 | $274K | Buy |
1,485
+34
| +2% | +$6.28K | ﹤0.01% | 995 |
|
2024
Q3 | $286K | Buy |
1,451
+1,044
| +257% | +$206K | ﹤0.01% | 962 |
|
2024
Q2 | $84K | Buy |
407
+14
| +4% | +$2.89K | 0.02% | 445 |
|
2024
Q1 | $106K | Buy |
393
+13
| +3% | +$3.51K | 0.02% | 411 |
|
2023
Q4 | $90K | Buy |
380
+15
| +4% | +$3.55K | 0.02% | 428 |
|
2023
Q3 | $72K | Buy |
365
+21
| +6% | +$4.14K | 0.02% | 421 |
|
2023
Q2 | $72K | Buy |
344
+74
| +27% | +$15.5K | 0.02% | 428 |
|
2023
Q1 | $54K | Buy |
270
+54
| +25% | +$10.8K | 0.01% | 452 |
|
2022
Q4 | $47K | Sell |
216
-81
| -27% | -$17.6K | 0.01% | 423 |
|
2022
Q3 | $58K | Buy |
297
+33
| +13% | +$6.44K | 0.02% | 405 |
|
2022
Q2 | $56K | Buy |
264
+32
| +14% | +$6.79K | 0.02% | 418 |
|
2022
Q1 | $66K | Buy |
232
+115
| +98% | +$32.7K | 0.02% | 424 |
|
2021
Q4 | $44K | Buy |
117
+6
| +5% | +$2.26K | 0.01% | 430 |
|
2021
Q3 | $46K | Hold |
111
| – | – | 0.03% | 315 |
|
2021
Q2 | $41K | Buy |
+111
| New | +$41K | 0.03% | 285 |
|